Insider filing · RAPP
Rapport Therapeutics, Inc.
RAPP · Healthcare · 32 filings in 24 months
ticker →
Third Rock Ventures VI, L.P. sold $17.2M of Rapport Therapeutics (RAPP)
Executed Apr 17, disclosed Apr 21, 4 days later.
Value, as filed
$17.2M
426,005 sh × $40.32
Executed
Apr 17
the trade date, as filed
Disclosed
Apr 21
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
TP
Third Rock Ventures VI, L.P.
10% owner
profile →
Third Rock Ventures VI, L.P. (10% owner) filed 2 Form 4 reports as a reporting entity in the trailing twelve months (0 purchases, 2 sales), most often in Rapport Therapeutics, Inc. (RAPP). The largest single filing was $17.2M of RAPP (426,005 sh × $40.32, as filed), executed Apr 17.
The name
RAPPHealthcare · Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transfo…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Third Rock Ventures VI, L.P. in RAPP
RAPPSALE
Rapport Therapeutics, Inc.
$11.1M276,513 sh across 2 lots
Exec May 7
Filed May 11 · 5:30 PM ET